Jan 25 (Reuters) - Abbott Laboratories reported
quarterly sales just shy of Wall Street expectations, largely
weighed by a strong dollar and waning demand for its nutrition
products, and forecast current-quarter adjusted profit below
estimates.
Read more
No comments:
Post a Comment